Susquehanna Fundamental Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-154,045	Closed	-$1.29M	–	728
2025 Q1	$1.29M	Buy	+154,045	New	+$1.29M	0.02%	635
2023 Q3	–	Sell	-17,064	Closed	-$52.9K	–	371
2023 Q2	$52.9K	Sell	17,064 -42,400	-71%	-$90.3K	﹤0.01%	620
2023 Q1	$82.7K	Sell	59,464 -8,060	-12%	-$16K	﹤0.01%	909
2022 Q4	$134K	Sell	67,524 -106,084	-61%	-$238K	﹤0.01%	1103
2022 Q3	$351K	Buy	+173,608	New	+$487K	0.01%	1114
2022 Q1	–	Sell	-42,100	Closed	-$202K	–	1528
2021 Q4	$202K	Sell	42,100 -54,519	-56%	-$272K	0.01%	1247
2021 Q3	$516K	Buy	96,619 +15,649	+19%	+$78.8K	0.01%	1189
2021 Q2	$415K	Sell	80,970 -23,205	-22%	-$132K	0.01%	1236
2021 Q1	$701K	Buy	+104,175	New	+$577K	0.01%	1021
2020 Q4	–	Sell	-119,600	Closed	-$464K	–	1485
2020 Q3	$464K	Buy	119,600 +15,500	+15%	+$66.3K	0.01%	901
2020 Q2	$496K	Buy	+104,100	New	+$429K	0.02%	618

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's AMRX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Amneal Pharmaceuticals (AMRX) in Q2 2025, closing a stake of 154,045 shares — an estimated $1.29M sold.

Susquehanna Fundamental Investments first reported a position in AMRX in Q2 2020 and held it in 11 quarters. The position peaked at $1.29M in Q1 2025. 241 funds tracked by Wall St. Rank hold AMRX as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining Amneal Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 154,045 Amneal Pharmaceuticals shares in Q2 2025, an estimated $1.29M.
Susquehanna Fundamental Investments first reported a position in Amneal Pharmaceuticals in Q2 2020 and held it in 11 quarters.
Susquehanna Fundamental Investments's Amneal Pharmaceuticals position peaked at $1.29M in Q1 2025.
241 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.